We Test is a pioneering brand founded by Sophie Castleman and Professor David Gracey MBBS FRACP PhD FHEA in 2016. Their mission is to revolutionize healthcare, particularly in the comfort of one's home. Recognizing the rise of telehealth and patient empowerment, We Test provides innovative solutions in the healthcare industry.

Not only does We Test offer diagnostics through Point of Care, enabling individuals to monitor their health outside of traditional laboratories, but they also focus on research and development, regulatory affairs, and grant applications. Their team includes Professor Gracey, a Senior Staff Specialist Renal and Renal Transplant Physician, and Sophie Castleman, who has a deep business background with expertise in medical software. As a result of their dedication, We Test has become a leading representative of various healthcare products and has forged sales partnerships throughout Australasia.

They have received support from the Australian Government and collaborate with commercial partners to bring cutting-edge innovations to life. With a focus on manufacturing partnerships in The Republic of Korea, We Test offers a wide range of products for registration in Australasia and works closely with registration experts to include therapeutic products on the ARTG